HEADER VIRAL PROTEIN 26-APR-07 2POH TITLE STRUCTURE OF PHAGE P22 TAIL NEEDLE GP26 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAD COMPLETION PROTEIN; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SALMONELLA PHAGE P22-PBI; SOURCE 3 ORGANISM_TAXID: 200913; SOURCE 4 GENE: 26; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-15B KEYWDS TRIMERIC COILED-COIL, TRIPLE BETA-HELIX, HEPTAD, MEMBRANE- KEYWDS 2 PENETRATION, FIBER, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.S.OLIA,G.CINGOLANI REVDAT 4 20-OCT-21 2POH 1 SEQADV LINK REVDAT 3 28-APR-10 2POH 1 REMARK REVDAT 2 30-DEC-08 2POH 1 JRNL VERSN REVDAT 1 04-DEC-07 2POH 0 JRNL AUTH A.S.OLIA,S.CASJENS,G.CINGOLANI JRNL TITL STRUCTURE OF PHAGE P22 CELL ENVELOPE-PENETRATING NEEDLE. JRNL REF NAT.STRUCT.MOL.BIOL. V. 14 1221 2007 JRNL REFN ISSN 1545-9993 JRNL PMID 18059287 JRNL DOI 10.1038/NSMB1317 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.167 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 85617 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.167 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 85584 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 10375 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 886 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 11261. REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 85 REMARK 3 NUMBER OF RESTRAINTS : 15875 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 ANGLE DISTANCES (A) : 0.023 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.283 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.034 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.051 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.054 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.100 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.033 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.067 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.060 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 ANISOTROPIC REFINEMENT REDUCED FREE R (NO CUTOFF). THE DATA IS REMARK 3 TWINNED WITH TWINNING OPERATORS: REMARK 3 H, -K, -L, AND CORRESPONDING TWIN FRACTIONS 0.23239. REMARK 4 REMARK 4 2POH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042606. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAY-05; 25-JUL-06; NULL REMARK 200 TEMPERATURE (KELVIN) : 100; NULL; NULL REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y; Y REMARK 200 RADIATION SOURCE : NSLS; CHESS; SSRL REMARK 200 BEAMLINE : X6A; F2; BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; NULL; NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.979; 0.976; 0.97 REMARK 200 MONOCHROMATOR : NULL; NULL; NULL REMARK 200 OPTICS : NULL; NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD; NULL REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315; ADSC QUANTUM REMARK 200 210; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 90017 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07200 REMARK 200 FOR THE DATA SET : 15.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.35300 REMARK 200 R SYM FOR SHELL (I) : 0.35300 REMARK 200 FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD; NULL; NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% PEG8000; 0.1M AMMONIUM SULFATE, REMARK 280 0.05M NACL, 0.1M SODIUM ACETATE PH4.6, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 57.01450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ASYMETRIC UNIT CONTAINS 2 TRIMERS, THE TRIMER BEING REMARK 300 BIOLOGICALLY ACTIVE UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL D 10 CB CG1 CG2 REMARK 470 GLN D 149 CG CD OE1 NE2 REMARK 470 PRO D 154 CB CG CD REMARK 470 LEU D 155 CB CG CD1 CD2 REMARK 470 VAL D 157 CG1 CG2 REMARK 470 THR D 159 CB OG1 CG2 REMARK 470 LEU D 212 CB CG CD1 CD2 REMARK 470 ASP E 18 CB CG OD1 OD2 REMARK 470 VAL E 169 CB CG1 CG2 REMARK 470 LEU E 192 CG CD1 CD2 REMARK 470 ASP E 198 CG OD1 OD2 REMARK 470 GLU E 204 CB CG CD OE1 OE2 REMARK 470 ARG E 227 CB CG CD NE CZ NH1 NH2 REMARK 470 ALA E 228 CB REMARK 470 THR F 159 CB OG1 CG2 REMARK 470 ALA F 195 CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLN C 149 CD GLN C 149 NE2 0.285 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 172 CD - NE - CZ ANGL. DEV. = 19.6 DEGREES REMARK 500 ARG A 172 NE - CZ - NH1 ANGL. DEV. = -10.7 DEGREES REMARK 500 ARG A 172 NE - CZ - NH2 ANGL. DEV. = 11.2 DEGREES REMARK 500 ASP B 189 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 GLN C 149 N - CA - CB ANGL. DEV. = -12.1 DEGREES REMARK 500 GLN C 149 CB - CG - CD ANGL. DEV. = -17.1 DEGREES REMARK 500 TYR C 200 CA - CB - CG ANGL. DEV. = 15.9 DEGREES REMARK 500 THR C 201 CB - CA - C ANGL. DEV. = -22.3 DEGREES REMARK 500 ARG D 90 CD - NE - CZ ANGL. DEV. = 9.8 DEGREES REMARK 500 ARG D 90 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 HIS E 229 O - C - N ANGL. DEV. = -14.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 10 94.19 -57.76 REMARK 500 VAL A 11 98.62 -50.22 REMARK 500 GLN A 13 78.81 -64.12 REMARK 500 ALA A 14 125.44 174.35 REMARK 500 THR A 15 -178.18 -64.46 REMARK 500 ARG A 16 -170.68 -62.58 REMARK 500 LEU A 17 -76.25 -100.65 REMARK 500 ASP A 18 110.19 51.75 REMARK 500 ALA A 19 -38.07 -32.74 REMARK 500 ASP A 139 17.15 -159.90 REMARK 500 SER A 142 119.29 64.72 REMARK 500 LYS A 143 -71.08 -60.60 REMARK 500 ALA A 145 110.09 166.17 REMARK 500 ALA A 152 -2.81 76.18 REMARK 500 ALA A 179 -159.65 -74.69 REMARK 500 ALA A 190 40.66 -54.05 REMARK 500 ASP A 191 142.77 -8.09 REMARK 500 LEU A 192 58.40 -90.55 REMARK 500 PHE A 194 -111.56 -49.83 REMARK 500 ALA A 195 74.59 38.22 REMARK 500 TYR A 200 -94.65 8.50 REMARK 500 THR A 201 106.52 76.66 REMARK 500 THR B 159 -27.81 78.26 REMARK 500 SER B 160 166.38 170.73 REMARK 500 VAL B 168 -30.65 -137.13 REMARK 500 ALA B 171 152.03 -48.26 REMARK 500 GLN B 173 96.03 57.44 REMARK 500 THR B 174 -155.63 -101.89 REMARK 500 ALA B 190 60.54 -66.20 REMARK 500 LEU B 192 161.08 -43.24 REMARK 500 THR B 193 -153.32 -96.50 REMARK 500 PHE B 194 -44.81 -148.95 REMARK 500 ALA B 195 111.84 85.13 REMARK 500 ASP B 198 -81.73 -45.07 REMARK 500 TYR B 200 -77.98 -31.53 REMARK 500 THR B 201 99.10 61.87 REMARK 500 ALA C 2 90.60 58.07 REMARK 500 LEU C 17 -149.49 -90.16 REMARK 500 ASP C 18 -146.92 -159.03 REMARK 500 PRO C 23 -146.05 -55.77 REMARK 500 ARG C 24 -54.40 -137.91 REMARK 500 VAL C 26 -53.16 -148.02 REMARK 500 VAL C 141 110.63 56.32 REMARK 500 SER C 150 164.69 -14.11 REMARK 500 VAL C 157 -154.13 -107.39 REMARK 500 THR C 158 -75.71 -106.20 REMARK 500 SER C 160 155.21 175.01 REMARK 500 VAL C 187 126.45 -13.85 REMARK 500 LEU C 192 102.79 23.05 REMARK 500 THR C 193 -73.46 -93.08 REMARK 500 REMARK 500 THIS ENTRY HAS 138 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL C 196 SER C 197 111.94 REMARK 500 THR C 199 TYR C 200 141.10 REMARK 500 SER C 203 GLU C 204 -130.06 REMARK 500 MSE D 1 ALA D 2 -103.18 REMARK 500 ALA D 2 ASP D 3 -107.40 REMARK 500 ASN D 7 ASN D 8 -141.05 REMARK 500 ALA D 152 SER D 153 -136.48 REMARK 500 SER D 153 PRO D 154 51.15 REMARK 500 PHE D 188 ASP D 189 -129.17 REMARK 500 ASP D 189 ALA D 190 -132.48 REMARK 500 ASN E 156 VAL E 157 -135.65 REMARK 500 THR E 158 THR E 159 -121.40 REMARK 500 VAL F 168 VAL F 169 -136.69 REMARK 500 VAL F 169 GLY F 170 -119.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 HIS E 229 -23.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LKT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HEAD-BINDING DOMAIN OF PHAGE P22 TAILSPIKE REMARK 900 PROTEIN DBREF 2POH A 1 233 UNP Q8LTG5 Q8LTG5_BPP22 1 233 DBREF 2POH B 1 233 UNP Q8LTG5 Q8LTG5_BPP22 1 233 DBREF 2POH C 1 233 UNP Q8LTG5 Q8LTG5_BPP22 1 233 DBREF 2POH D 1 233 UNP Q8LTG5 Q8LTG5_BPP22 1 233 DBREF 2POH E 1 233 UNP Q8LTG5 Q8LTG5_BPP22 1 233 DBREF 2POH F 1 233 UNP Q8LTG5 Q8LTG5_BPP22 1 233 SEQADV 2POH MSE A 1 UNP Q8LTG5 MET 1 MODIFIED RESIDUE SEQADV 2POH MSE A 222 UNP Q8LTG5 LEU 222 ENGINEERED MUTATION SEQADV 2POH MSE B 1 UNP Q8LTG5 MET 1 MODIFIED RESIDUE SEQADV 2POH MSE B 222 UNP Q8LTG5 LEU 222 ENGINEERED MUTATION SEQADV 2POH MSE C 1 UNP Q8LTG5 MET 1 MODIFIED RESIDUE SEQADV 2POH MSE C 222 UNP Q8LTG5 LEU 222 ENGINEERED MUTATION SEQADV 2POH MSE D 1 UNP Q8LTG5 MET 1 MODIFIED RESIDUE SEQADV 2POH MSE D 222 UNP Q8LTG5 LEU 222 ENGINEERED MUTATION SEQADV 2POH MSE E 1 UNP Q8LTG5 MET 1 MODIFIED RESIDUE SEQADV 2POH MSE E 222 UNP Q8LTG5 LEU 222 ENGINEERED MUTATION SEQADV 2POH MSE F 1 UNP Q8LTG5 MET 1 MODIFIED RESIDUE SEQADV 2POH MSE F 222 UNP Q8LTG5 LEU 222 ENGINEERED MUTATION SEQRES 1 A 233 MSE ALA ASP PRO SER LEU ASN ASN PRO VAL VAL ILE GLN SEQRES 2 A 233 ALA THR ARG LEU ASP ALA SER ILE LEU PRO ARG ASN VAL SEQRES 3 A 233 PHE SER LYS SER TYR LEU LEU TYR VAL ILE ALA GLN GLY SEQRES 4 A 233 THR ASP VAL GLY ALA ILE ALA GLY LYS ALA ASN GLU ALA SEQRES 5 A 233 GLY GLN GLY ALA TYR ASP ALA GLN VAL LYS ASN ASP GLU SEQRES 6 A 233 GLN ASP VAL GLU LEU ALA ASP HIS GLU ALA ARG ILE LYS SEQRES 7 A 233 GLN LEU ARG ILE ASP VAL ASP ASP HIS GLU SER ARG ILE SEQRES 8 A 233 THR ALA ASN THR LYS ALA ILE THR ALA LEU ASN VAL ARG SEQRES 9 A 233 VAL THR THR ALA GLU GLY GLU ILE ALA SER LEU GLN THR SEQRES 10 A 233 ASN VAL SER ALA LEU ASP GLY ARG VAL THR THR ALA GLU SEQRES 11 A 233 ASN ASN ILE SER ALA LEU GLN ALA ASP TYR VAL SER LYS SEQRES 12 A 233 THR ALA THR THR SER GLN SER LEU ALA SER PRO LEU ASN SEQRES 13 A 233 VAL THR THR SER TYR SER VAL GLY GLY LYS LYS VAL VAL SEQRES 14 A 233 GLY ALA ARG GLN THR GLY TRP THR ALA ALA THR GLY THR SEQRES 15 A 233 ALA ASN LYS GLY VAL PHE ASP ALA ASP LEU THR PHE ALA SEQRES 16 A 233 VAL SER ASP THR TYR THR GLN SER GLU ILE GLN ALA ILE SEQRES 17 A 233 ALA ASN ALA LEU ILE THR GLU ARG ARG ARG THR LYS ALA SEQRES 18 A 233 MSE GLU ASP ALA LEU ARG ALA HIS GLY LEU ILE ASP SEQRES 1 B 233 MSE ALA ASP PRO SER LEU ASN ASN PRO VAL VAL ILE GLN SEQRES 2 B 233 ALA THR ARG LEU ASP ALA SER ILE LEU PRO ARG ASN VAL SEQRES 3 B 233 PHE SER LYS SER TYR LEU LEU TYR VAL ILE ALA GLN GLY SEQRES 4 B 233 THR ASP VAL GLY ALA ILE ALA GLY LYS ALA ASN GLU ALA SEQRES 5 B 233 GLY GLN GLY ALA TYR ASP ALA GLN VAL LYS ASN ASP GLU SEQRES 6 B 233 GLN ASP VAL GLU LEU ALA ASP HIS GLU ALA ARG ILE LYS SEQRES 7 B 233 GLN LEU ARG ILE ASP VAL ASP ASP HIS GLU SER ARG ILE SEQRES 8 B 233 THR ALA ASN THR LYS ALA ILE THR ALA LEU ASN VAL ARG SEQRES 9 B 233 VAL THR THR ALA GLU GLY GLU ILE ALA SER LEU GLN THR SEQRES 10 B 233 ASN VAL SER ALA LEU ASP GLY ARG VAL THR THR ALA GLU SEQRES 11 B 233 ASN ASN ILE SER ALA LEU GLN ALA ASP TYR VAL SER LYS SEQRES 12 B 233 THR ALA THR THR SER GLN SER LEU ALA SER PRO LEU ASN SEQRES 13 B 233 VAL THR THR SER TYR SER VAL GLY GLY LYS LYS VAL VAL SEQRES 14 B 233 GLY ALA ARG GLN THR GLY TRP THR ALA ALA THR GLY THR SEQRES 15 B 233 ALA ASN LYS GLY VAL PHE ASP ALA ASP LEU THR PHE ALA SEQRES 16 B 233 VAL SER ASP THR TYR THR GLN SER GLU ILE GLN ALA ILE SEQRES 17 B 233 ALA ASN ALA LEU ILE THR GLU ARG ARG ARG THR LYS ALA SEQRES 18 B 233 MSE GLU ASP ALA LEU ARG ALA HIS GLY LEU ILE ASP SEQRES 1 C 233 MSE ALA ASP PRO SER LEU ASN ASN PRO VAL VAL ILE GLN SEQRES 2 C 233 ALA THR ARG LEU ASP ALA SER ILE LEU PRO ARG ASN VAL SEQRES 3 C 233 PHE SER LYS SER TYR LEU LEU TYR VAL ILE ALA GLN GLY SEQRES 4 C 233 THR ASP VAL GLY ALA ILE ALA GLY LYS ALA ASN GLU ALA SEQRES 5 C 233 GLY GLN GLY ALA TYR ASP ALA GLN VAL LYS ASN ASP GLU SEQRES 6 C 233 GLN ASP VAL GLU LEU ALA ASP HIS GLU ALA ARG ILE LYS SEQRES 7 C 233 GLN LEU ARG ILE ASP VAL ASP ASP HIS GLU SER ARG ILE SEQRES 8 C 233 THR ALA ASN THR LYS ALA ILE THR ALA LEU ASN VAL ARG SEQRES 9 C 233 VAL THR THR ALA GLU GLY GLU ILE ALA SER LEU GLN THR SEQRES 10 C 233 ASN VAL SER ALA LEU ASP GLY ARG VAL THR THR ALA GLU SEQRES 11 C 233 ASN ASN ILE SER ALA LEU GLN ALA ASP TYR VAL SER LYS SEQRES 12 C 233 THR ALA THR THR SER GLN SER LEU ALA SER PRO LEU ASN SEQRES 13 C 233 VAL THR THR SER TYR SER VAL GLY GLY LYS LYS VAL VAL SEQRES 14 C 233 GLY ALA ARG GLN THR GLY TRP THR ALA ALA THR GLY THR SEQRES 15 C 233 ALA ASN LYS GLY VAL PHE ASP ALA ASP LEU THR PHE ALA SEQRES 16 C 233 VAL SER ASP THR TYR THR GLN SER GLU ILE GLN ALA ILE SEQRES 17 C 233 ALA ASN ALA LEU ILE THR GLU ARG ARG ARG THR LYS ALA SEQRES 18 C 233 MSE GLU ASP ALA LEU ARG ALA HIS GLY LEU ILE ASP SEQRES 1 D 233 MSE ALA ASP PRO SER LEU ASN ASN PRO VAL VAL ILE GLN SEQRES 2 D 233 ALA THR ARG LEU ASP ALA SER ILE LEU PRO ARG ASN VAL SEQRES 3 D 233 PHE SER LYS SER TYR LEU LEU TYR VAL ILE ALA GLN GLY SEQRES 4 D 233 THR ASP VAL GLY ALA ILE ALA GLY LYS ALA ASN GLU ALA SEQRES 5 D 233 GLY GLN GLY ALA TYR ASP ALA GLN VAL LYS ASN ASP GLU SEQRES 6 D 233 GLN ASP VAL GLU LEU ALA ASP HIS GLU ALA ARG ILE LYS SEQRES 7 D 233 GLN LEU ARG ILE ASP VAL ASP ASP HIS GLU SER ARG ILE SEQRES 8 D 233 THR ALA ASN THR LYS ALA ILE THR ALA LEU ASN VAL ARG SEQRES 9 D 233 VAL THR THR ALA GLU GLY GLU ILE ALA SER LEU GLN THR SEQRES 10 D 233 ASN VAL SER ALA LEU ASP GLY ARG VAL THR THR ALA GLU SEQRES 11 D 233 ASN ASN ILE SER ALA LEU GLN ALA ASP TYR VAL SER LYS SEQRES 12 D 233 THR ALA THR THR SER GLN SER LEU ALA SER PRO LEU ASN SEQRES 13 D 233 VAL THR THR SER TYR SER VAL GLY GLY LYS LYS VAL VAL SEQRES 14 D 233 GLY ALA ARG GLN THR GLY TRP THR ALA ALA THR GLY THR SEQRES 15 D 233 ALA ASN LYS GLY VAL PHE ASP ALA ASP LEU THR PHE ALA SEQRES 16 D 233 VAL SER ASP THR TYR THR GLN SER GLU ILE GLN ALA ILE SEQRES 17 D 233 ALA ASN ALA LEU ILE THR GLU ARG ARG ARG THR LYS ALA SEQRES 18 D 233 MSE GLU ASP ALA LEU ARG ALA HIS GLY LEU ILE ASP SEQRES 1 E 233 MSE ALA ASP PRO SER LEU ASN ASN PRO VAL VAL ILE GLN SEQRES 2 E 233 ALA THR ARG LEU ASP ALA SER ILE LEU PRO ARG ASN VAL SEQRES 3 E 233 PHE SER LYS SER TYR LEU LEU TYR VAL ILE ALA GLN GLY SEQRES 4 E 233 THR ASP VAL GLY ALA ILE ALA GLY LYS ALA ASN GLU ALA SEQRES 5 E 233 GLY GLN GLY ALA TYR ASP ALA GLN VAL LYS ASN ASP GLU SEQRES 6 E 233 GLN ASP VAL GLU LEU ALA ASP HIS GLU ALA ARG ILE LYS SEQRES 7 E 233 GLN LEU ARG ILE ASP VAL ASP ASP HIS GLU SER ARG ILE SEQRES 8 E 233 THR ALA ASN THR LYS ALA ILE THR ALA LEU ASN VAL ARG SEQRES 9 E 233 VAL THR THR ALA GLU GLY GLU ILE ALA SER LEU GLN THR SEQRES 10 E 233 ASN VAL SER ALA LEU ASP GLY ARG VAL THR THR ALA GLU SEQRES 11 E 233 ASN ASN ILE SER ALA LEU GLN ALA ASP TYR VAL SER LYS SEQRES 12 E 233 THR ALA THR THR SER GLN SER LEU ALA SER PRO LEU ASN SEQRES 13 E 233 VAL THR THR SER TYR SER VAL GLY GLY LYS LYS VAL VAL SEQRES 14 E 233 GLY ALA ARG GLN THR GLY TRP THR ALA ALA THR GLY THR SEQRES 15 E 233 ALA ASN LYS GLY VAL PHE ASP ALA ASP LEU THR PHE ALA SEQRES 16 E 233 VAL SER ASP THR TYR THR GLN SER GLU ILE GLN ALA ILE SEQRES 17 E 233 ALA ASN ALA LEU ILE THR GLU ARG ARG ARG THR LYS ALA SEQRES 18 E 233 MSE GLU ASP ALA LEU ARG ALA HIS GLY LEU ILE ASP SEQRES 1 F 233 MSE ALA ASP PRO SER LEU ASN ASN PRO VAL VAL ILE GLN SEQRES 2 F 233 ALA THR ARG LEU ASP ALA SER ILE LEU PRO ARG ASN VAL SEQRES 3 F 233 PHE SER LYS SER TYR LEU LEU TYR VAL ILE ALA GLN GLY SEQRES 4 F 233 THR ASP VAL GLY ALA ILE ALA GLY LYS ALA ASN GLU ALA SEQRES 5 F 233 GLY GLN GLY ALA TYR ASP ALA GLN VAL LYS ASN ASP GLU SEQRES 6 F 233 GLN ASP VAL GLU LEU ALA ASP HIS GLU ALA ARG ILE LYS SEQRES 7 F 233 GLN LEU ARG ILE ASP VAL ASP ASP HIS GLU SER ARG ILE SEQRES 8 F 233 THR ALA ASN THR LYS ALA ILE THR ALA LEU ASN VAL ARG SEQRES 9 F 233 VAL THR THR ALA GLU GLY GLU ILE ALA SER LEU GLN THR SEQRES 10 F 233 ASN VAL SER ALA LEU ASP GLY ARG VAL THR THR ALA GLU SEQRES 11 F 233 ASN ASN ILE SER ALA LEU GLN ALA ASP TYR VAL SER LYS SEQRES 12 F 233 THR ALA THR THR SER GLN SER LEU ALA SER PRO LEU ASN SEQRES 13 F 233 VAL THR THR SER TYR SER VAL GLY GLY LYS LYS VAL VAL SEQRES 14 F 233 GLY ALA ARG GLN THR GLY TRP THR ALA ALA THR GLY THR SEQRES 15 F 233 ALA ASN LYS GLY VAL PHE ASP ALA ASP LEU THR PHE ALA SEQRES 16 F 233 VAL SER ASP THR TYR THR GLN SER GLU ILE GLN ALA ILE SEQRES 17 F 233 ALA ASN ALA LEU ILE THR GLU ARG ARG ARG THR LYS ALA SEQRES 18 F 233 MSE GLU ASP ALA LEU ARG ALA HIS GLY LEU ILE ASP MODRES 2POH MSE A 1 MET SELENOMETHIONINE MODRES 2POH MSE A 222 MET SELENOMETHIONINE MODRES 2POH MSE B 1 MET SELENOMETHIONINE MODRES 2POH MSE B 222 MET SELENOMETHIONINE MODRES 2POH MSE C 1 MET SELENOMETHIONINE MODRES 2POH MSE C 222 MET SELENOMETHIONINE MODRES 2POH MSE D 1 MET SELENOMETHIONINE MODRES 2POH MSE D 222 MET SELENOMETHIONINE MODRES 2POH MSE E 1 MET SELENOMETHIONINE MODRES 2POH MSE E 222 MET SELENOMETHIONINE MODRES 2POH MSE F 1 MET SELENOMETHIONINE MODRES 2POH MSE F 222 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 222 8 HET MSE B 1 8 HET MSE B 222 8 HET MSE C 1 8 HET MSE C 222 8 HET MSE D 1 8 HET MSE D 222 8 HET MSE E 1 8 HET MSE E 222 8 HET MSE F 1 8 HET MSE F 222 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 7 HOH *886(H2 O) HELIX 1 1 ASP A 3 ASN A 8 5 6 HELIX 2 2 ASP A 18 LEU A 22 5 5 HELIX 3 3 SER A 28 ALA A 138 1 111 HELIX 4 4 THR A 201 GLY A 230 1 30 HELIX 5 5 ASP B 3 ASN B 8 5 6 HELIX 6 6 ASP B 18 LEU B 22 5 5 HELIX 7 7 LYS B 29 ALA B 138 1 110 HELIX 8 8 THR B 201 GLY B 230 1 30 HELIX 9 9 ASP C 3 ASN C 8 5 6 HELIX 10 10 SER C 28 ASP C 139 1 112 HELIX 11 11 ILE C 205 GLY C 230 1 26 HELIX 12 12 SER D 28 TYR D 140 1 113 HELIX 13 13 THR D 201 ALA D 211 1 11 HELIX 14 14 GLU D 215 HIS D 229 1 15 HELIX 15 15 ASP E 3 ASN E 8 5 6 HELIX 16 16 SER E 28 TYR E 140 1 113 HELIX 17 17 GLN E 206 ARG E 227 1 22 HELIX 18 18 SER F 30 ALA F 138 1 109 HELIX 19 19 ALA F 207 ASN F 210 5 4 HELIX 20 20 ALA F 211 GLY F 230 1 20 SHEET 1 A 4 GLN A 149 SER A 150 0 SHEET 2 A 4 LEU C 155 VAL C 157 1 O ASN C 156 N GLN A 149 SHEET 3 A 4 TYR B 161 VAL B 163 1 N SER B 162 O VAL C 157 SHEET 4 A 4 LYS B 166 VAL B 169 -1 O VAL B 168 N TYR B 161 SHEET 1 B 3 LYS A 166 VAL A 169 0 SHEET 2 B 3 TYR A 161 VAL A 163 -1 N TYR A 161 O VAL A 168 SHEET 3 B 3 LEU B 155 VAL B 157 1 O VAL B 157 N SER A 162 SHEET 1 C 2 TYR C 161 VAL C 163 0 SHEET 2 C 2 LYS C 166 VAL C 169 -1 O LYS C 166 N VAL C 163 SHEET 1 D 4 LYS D 166 VAL D 169 0 SHEET 2 D 4 TYR D 161 VAL D 163 -1 N VAL D 163 O LYS D 166 SHEET 3 D 4 LEU F 155 VAL F 157 1 O LEU F 155 N SER D 162 SHEET 4 D 4 GLN E 149 SER E 150 1 N GLN E 149 O ASN F 156 SHEET 1 E 2 SER E 162 VAL E 163 0 SHEET 2 E 2 LYS E 166 LYS E 167 -1 O LYS E 166 N VAL E 163 SHEET 1 F 2 PHE E 188 ASP E 189 0 SHEET 2 F 2 ALA F 179 THR F 180 1 O THR F 180 N PHE E 188 SHEET 1 G 2 SER F 160 VAL F 163 0 SHEET 2 G 2 LYS F 166 GLY F 170 -1 O VAL F 168 N TYR F 161 LINK C MSE A 1 N ALA A 2 1555 1555 1.32 LINK C ALA A 221 N MSE A 222 1555 1555 1.32 LINK C MSE A 222 N GLU A 223 1555 1555 1.33 LINK C MSE B 1 N ALA B 2 1555 1555 1.33 LINK C ALA B 221 N MSE B 222 1555 1555 1.33 LINK C MSE B 222 N GLU B 223 1555 1555 1.33 LINK C MSE C 1 N ALA C 2 1555 1555 1.33 LINK C ALA C 221 N MSE C 222 1555 1555 1.33 LINK C MSE C 222 N GLU C 223 1555 1555 1.32 LINK C MSE D 1 N ALA D 2 1555 1555 1.33 LINK C ALA D 221 N MSE D 222 1555 1555 1.33 LINK C MSE D 222 N GLU D 223 1555 1555 1.33 LINK C MSE E 1 N ALA E 2 1555 1555 1.33 LINK C ALA E 221 N MSE E 222 1555 1555 1.33 LINK C MSE E 222 N GLU E 223 1555 1555 1.33 LINK C MSE F 1 N ALA F 2 1555 1555 1.33 LINK C ALA F 221 N MSE F 222 1555 1555 1.33 LINK C MSE F 222 N GLU F 223 1555 1555 1.33 CRYST1 40.398 114.029 171.917 90.00 90.74 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024754 0.000000 0.000320 0.00000 SCALE2 0.000000 0.008770 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005817 0.00000 HETATM 1 N MSE A 1 44.790 33.600 135.346 1.00 42.99 N ANISOU 1 N MSE A 1 4142 4261 7930 -1405 -1457 -1396 N HETATM 2 CA MSE A 1 45.270 34.965 135.388 1.00 35.93 C ANISOU 2 CA MSE A 1 3784 4178 5691 -1279 -1182 -841 C HETATM 3 C MSE A 1 46.431 35.126 136.361 1.00 32.22 C ANISOU 3 C MSE A 1 4206 3580 4457 -1065 -934 -908 C HETATM 4 O MSE A 1 46.339 34.765 137.535 1.00 32.73 O ANISOU 4 O MSE A 1 2209 6111 4114 -800 687 -1525 O HETATM 5 CB MSE A 1 44.156 35.970 135.684 1.00 39.66 C ANISOU 5 CB MSE A 1 4196 4417 6455 -923 -1196 -893 C HETATM 6 CG MSE A 1 44.691 37.378 136.029 1.00 42.26 C ANISOU 6 CG MSE A 1 4755 4325 6977 -988 -736 -1008 C HETATM 7 SE MSE A 1 46.268 37.769 135.215 1.00124.81 SE ANISOU 7 SE MSE A 1 19790 20000 7631 14891 8200 11122 SE HETATM 8 CE MSE A 1 46.650 39.440 136.003 1.00 11.79 C ANISOU 8 CE MSE A 1 3414 0 1067 -2213 -475 -332 C